<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17427" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Amaurosis Fugax</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tadi</surname>
            <given-names>Prasanna</given-names>
          </name>
          <aff>Asram Medical College, Eluru, India</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Najem</surname>
            <given-names>Kinda</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Margolin</surname>
            <given-names>Edward</given-names>
          </name>
          <aff>University of Toronto</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Prasanna Tadi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kinda Najem declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Edward Margolin declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>7</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17427.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>The term amaurosis fugax is often used interchangeably to describe transient visual loss (TVL). However, it is employed widely in medicine to refer to any cause of transient monocular visual loss. Amaurosis fugax is a harbinger of an imminent stroke. This activity describes the causes, presentation, and diagnosis of amaurosis fugax and highlights the role of the interprofessional team in the management of these patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the etiology of amaurosis fugax with special attention to the diseases presenting with this symptom.</p></list-item><list-item><p>Describe the pathophysiology behind the phenomenon of amaurosis fugax.</p></list-item><list-item><p>Summarize the clinical evaluation and differential diagnosis for diseases presenting with amaurosis fugax.</p></list-item><list-item><p>Explain the importance of improving care coordination among the interprofessional team to enhance the delivery of care for patients presenting with amaurosis fugax.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17427&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17427">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17427.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The term amaurosis fugax is often used interchangeably to describe transient visual loss (TVL). However, it is employed widely in medicine to refer to any cause of transient monocular visual loss. Here, we will refer to amaurosis fugax only in the context of&#x000a0;transient monocular visual loss associated with vascular thromboembolic events arising from the internal carotid arterial system.&#x000a0;<xref ref-type="bibr" rid="article-17427.r1">[1]</xref>,<xref ref-type="bibr" rid="article-17427.r2">[2]</xref>,<xref ref-type="bibr" rid="article-17427.r3">[3]</xref></p>
        <p>The condition is not common in children and more likely to have a benign cause. In adults, in most cases, the cause is atherosclerotic emboli from the carotid artery bifurcation.</p>
      </sec>
      <sec id="article-17427.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Amaurosis fugax is a result of an occlusion or stenosis of the internal carotid artery circulation. Thromboembolism originating from the carotid circulation, as well as hypoperfusion caused by the stenosis of this circulation, are the underlying mechanisms. The ocular ischemic syndrome results from chronic hypoperfusion due to unilateral or bilateral carotid artery occlusion.&#x000a0;<xref ref-type="bibr" rid="article-17427.r3">[3]</xref></p>
      </sec>
      <sec id="article-17427.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Amaurosis fugax usually occurs in patients over the age of 50 who have other vascular risk factors which include hypertension, hypercholesterolemia, smoking, previous episodes of transient ischemic attacks (TIAs), and claudication. The risk of hemispheric stroke in patients with amaurosis fugax is estimated to be 2% per year and 3% per year for those presenting with retinal emboli.</p>
        <p>Risk factors for amaurosis fugax include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Diabetes</p>
          </list-item>
          <list-item>
            <p>Heart disease</p>
          </list-item>
          <list-item>
            <p>Smoking</p>
          </list-item>
          <list-item>
            <p>Hypertension</p>
          </list-item>
          <list-item>
            <p>Hyperlipidemia</p>
          </list-item>
          <list-item>
            <p>Advanced age</p>
          </list-item>
          <list-item>
            <p>Use of cocaine</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17427.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Amaurosis fugax&#x000a0;may occur due to&#x000a0;the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Thromboembolism from a carotid plaque</p>
          </list-item>
          <list-item>
            <p>Hypoperfusion</p>
          </list-item>
          <list-item>
            <p>Vasospasm</p>
          </list-item>
          <list-item>
            <p>Elevated plasma viscosity, for example with leukemia, multiple myeloma</p>
          </list-item>
          <list-item>
            <p>Atherosclerotic cerebrovascular disease</p>
          </list-item>
        </list>
        <p>In amaurosis fugax, the loss of vision is usually unilateral, painless and transient. In most cases, the vision loss may vary from a few seconds to a few minutes. The embolus in most cases is from an atherosclerotic plaque in the carotid bifurcation. Hypoperfusion from any cause can also mimic amaurosis fugax.&#x000a0;</p>
      </sec>
      <sec id="article-17427.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>During the retinal examination, the health care provider may see the cholesterol plaque lodged within a retinal vessel. It is known as a Hollenhorst&#x000a0;plaque, and the cholesterol particle appears refractile, yellow, and bright.&#x000a0;<xref ref-type="bibr" rid="article-17427.r4">[4]</xref></p>
      </sec>
      <sec id="article-17427.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients complain of sudden monocular vision loss that can last between 2 to 30 minutes. The vision loss can involve the entire visual field or can be partial. Patients often describe it as a "curtain coming down&#x0201d; in front of their eye or as a generalized darkening or shadow. These episodes spontaneously resolve. Patients can experience 1 or multiple episodes. In anyone over the age of 60 experiencing multiple episodes, giant cell arteritis should be suspected, and further investigations should be undertaken.</p>
        <p>Some patients can present with signs of intraretinal emboli, such as cholesterol plaques (Hollenhorst plaques). Depending on the extent of the resulting retinal ischemia, central retinal artery occlusion or branch retinal artery occlusion can develop.</p>
        <p>In some patients, particularly those with the ocular ischemic syndrome, exposure to bright lights can provoke the episodes, as the ipsilateral severe internal carotid occlusion causes hypoperfusion of the retinal circulation and the resulting vascular insufficiency of the retinal photoreceptors combined with increased metabolic demand leads to blurred or decreased vision in those patients. Vision usually returns to normal once the photoreceptors have completely hyperpolarized.</p>
        <p>Patients with ocular ischemic syndrome typically present with blurred vision that can be transient. The visual acuity declines with the progression of the disease. The affected eye shows episcleral injection and, on slit-lamp examination, minimal anterior chamber inflammation is present. Intraocular pressure can be low or normal due to the decreased perfusion of the ciliary body which is&#x000a0;responsible for aqueous production. The fundus examination usually demonstrates dilated and tortuous retinal veins with narrowed arterioles accompanied by mid-peripheral dot-and-blot retinal hemorrhages. With persistent hypoperfusion, ischemia progresses and manifests as neovascularization of the iris, anterior chamber angle, retina, and optic disc. Ocular pain is a hallmark of the disease and is usually alleviated in the supine position. The latter is a result of ischemia of the ocular and orbital branches of the trigeminal nerve.&#x000a0;<xref ref-type="bibr" rid="article-17427.r5">[5]</xref></p>
      </sec>
      <sec id="article-17427.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Assessment of vascular risk factors is most important in anyone presenting with symptoms of amaurosis fugax. Patients should be assessed for hypertension, diabetes mellitus, hyperlipidemia, cardiac disease and asked about tobacco use. A careful physical examination, including full ophthalmological examination with a dilated fundus examination,&#x000a0;as well as auscultation of the carotid arteries and the heart, should be performed. Blood work, including a complete blood count, blood glucose level, lipid profile, prothrombin time and partial thromboplastin time, erythrocyte sedimentation rate and C-reactive protein should be ordered&#x000a0;as well.&#x000a0;<xref ref-type="bibr" rid="article-17427.r6">[6]</xref>,<xref ref-type="bibr" rid="article-17427.r7">[7]</xref></p>
        <p>Carotid Doppler is a non-invasive test used to assess the extracranial and intracranial status of the vessels. Magnetic resonance angiography and computed tomography angiography can also be used to&#x000a0;evaluate the patency of the internal carotid arteries.</p>
        <p>An electrocardiogram, as well as Holter monitoring, and,&#x000a0;in some cases, transesophageal echocardiography, should be obtained to rule out any possible&#x000a0;source of rhythmic disturbance or cardiac emboli.</p>
        <p>Neuroimaging studies are almost always done to rule out other causes of vision loss. In addition, the CT scan can help rule out a hemorrhagic lesion in the brain.</p>
      </sec>
      <sec id="article-17427.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment is first aimed at controlling and treating the underlying vascular risk factors, such as hypertension, diabetes, and hyperlipidemia.</p>
        <p>Two large studies, the North American Symptomatic Carotid Endarterectomy Trial (NASCET) and the European Carotid Surgery Trial (ECST) found that endarterectomy in symptomatic patients who have carotid stenosis greater than 70% reduces future risks of stroke. However, these studies did not address ocular TIAs separately. The NASCET further compared patients with hemispheric TIAs and ocular TIAs demonstrating that patients with hemispheric TIAs had a 2-year stroke incidence of about 44% compared to about 17% in ocular TIAs. The patients with ocular TIAs did not experience a major stroke episode, which was defined as a functional deficit persisting for more than 90 days. Both groups also had similar grades of carotid stenosis (about 83%).&#x000a0;<xref ref-type="bibr" rid="article-17427.r2">[2]</xref>,<xref ref-type="bibr" rid="article-17427.r8">[8]</xref>,<xref ref-type="bibr" rid="article-17427.r9">[9]</xref></p>
        <p>Therefore, the clinician needs to address if the risks of death and preoperative stroke in patients undergoing endarterectomy outweigh the low risk of observing these specific patients and treating them with anticoagulants alone, such as aspirin, warfarin or clopidogrel.</p>
        <p>It is important to note that both NASCET and ECST evaluated open endarterectomy but, since then, carotid stenting has become commonly used. Carotid stenting is comparable to endarterectomy, regarding treatment, and has similar low risks of death, stroke and myocardial infarction in patients with asymptomatic severe carotid artery stenosis.&#x000a0;<xref ref-type="bibr" rid="article-17427.r10">[10]</xref></p>
        <p>Treatment of ocular ischemic syndrome involves reducing the oxygen drive to the eye to decrease the neovascularization. This involves panretinal photocoagulation or intravitreal injections of anti-vascular endothelial growth factor (VEGF).</p>
      </sec>
      <sec id="article-17427.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of unilateral vision loss includes&#x000a0;the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Central retinal artery/vein occlusion</p>
          </list-item>
          <list-item>
            <p>Giant cell arteritis</p>
          </list-item>
          <list-item>
            <p>Multiple sclerosis</p>
          </list-item>
          <list-item>
            <p>Papilledema</p>
          </list-item>
          <list-item>
            <p>Epilepsy</p>
          </list-item>
          <list-item>
            <p>Sickle cell anemia</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17427.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>If amaurosis fugax is not diagnosed or treated, the patient risks a major stroke in the future. Most untreated patients with significant carotid artery plaques will develop a major stroke within 12 months. Those who undergo carotid endarterectomy have a good prognosis but the risk of adverse cardiac events still remains. Patients who do suffer a stroke have a guarded prognosis.</p>
      </sec>
      <sec id="article-17427.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The main complications of amaurosis fugax include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Stroke</p>
          </list-item>
          <list-item>
            <p>Death</p>
          </list-item>
          <list-item>
            <p>Adverse cardiac events</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17427.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Amaurosis fugax is a harbinger of an imminent stroke. The first study of choice is an ultrasound to determine the presence of&#x000a0;carotid artery stenosis. When an individual has been diagnosed with amaurosis fugax, it is vital to refer the patient first to a neurologist to confirm the diagnosis and examine for any other neurological deficits. Since many of these patients are smokers and diabetics and may have hypertension, they need a thorough presurgical workup to ensure that they can undergo general or local anesthesia. The time to undergo carotid endarterectomy is variable but expert opinion states that&#x000a0;it should be within 4 to 8 weeks. <xref ref-type="bibr" rid="article-17427.r11">[11]</xref>,<xref ref-type="bibr" rid="article-17427.r12">[12]</xref> (Level C)</p>
        <p>While awaiting surgery, the nurse should educate the patient and the family on the dangers of smoking and the importance of blood pressure control. The pharmacist should make sure that the patient is on aspirin and compliant with his blood pressure and diabetes medications.&#x000a0;Before surgery, the patient should be advised to stop all blood thinners.</p>
        <p>An interdisciplinary team approach to patient care and education will lead to better outcomes. [Level 5]</p>
        <p>
<bold>Outcomes</bold>
</p>
        <p>There is a large amount of evidence to show that treating patients with amaurosis fugax can prevent a full-blown stroke. However, the treatment of carotid stenosis is in a state of flux. The condition can also be managed with angioplasty and stenting. For patients who are&#x000a0;unfit for surgery or those who are asymptomatic, the endovascular approach may be viable, but symptomatic patients need an open procedure. There still&#x000a0;remains debate as to&#x000a0;which procedure is safer and the data is mixed and confusing because of the heterogeneity of the patients. The most important thing is to ensure that a patient with amaurosis fugax gets the appropriate&#x000a0;referral to a neurologist first to confirm the diagnosis. The choice between a vascular or an endovascular procedure depends on personal&#x000a0;preference. Both are safe procedures, and both have a role in the treatment of this serious disorder. <xref ref-type="bibr" rid="article-17427.r13">[13]</xref>,<xref ref-type="bibr" rid="article-17427.r14">[14]</xref> (Level III) Whatever choice one makes, the person doing the procedure must be experienced, and have the support of an interprofessional team to achieve optimal outcomes. [Level 5]</p>
      </sec>
      <sec id="article-17427.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17427&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17427">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/amaurosis-fugax-transient-visual-loss-tvl/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17427">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17427/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17427">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-17427.s15">
        <fig id="article-17427.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Occlusion of the Internal Carotid Artery. Occlusion of the&#x000a0;internal carotid artery (ICA) results in collateral formation via the external carotid artery (ECA). Contributed by S Dulebohn, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Screen__Shot__2016-06-04__at__5.57.50__PM" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-17427.s16">
        <fig id="article-17427.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Arteries of the Eye, Ophthalmic Artery; Internal Carotid Artery Henry Vandyke Carter, Public Domain, via Wikimedia Commons</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Gray514" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-17427.s17">
        <fig id="article-17427.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Exposure and Isolation of External and Internal Carotid Artery Contributed by Erion Qaja, Wyckoff Heights Medical Center</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IMG_6240" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-17427.s18">
        <fig id="article-17427.image.f4" position="float" orientation="portrait">
          <caption>
            <p>amaurosis fugax Image courtesy S bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="amauf" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-17427.s19">
        <fig id="article-17427.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Carotid artery and nerves Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="carotid__bifurcation" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-17427.s20">
        <title>References</title>
        <ref id="article-17427.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pula</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Yuen</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Eyes and stroke: the visual aspects of cerebrovascular disease.</article-title>
            <source>Stroke Vasc Neurol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>2</volume>
            <issue>4</issue>
            <fpage>210</fpage>
            <page-range>210-220</page-range>
            <pub-id pub-id-type="pmid">29507782</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17427.r2">
          <label>2</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Qaja</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Theetha Kariyanna</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <chapter-title>Carotid Artery Surgery</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>24</day>
            <pub-id pub-id-type="pmid">28722976</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17427.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Makhkamova</surname>
                <given-names>D&#x0041a;</given-names>
              </name>
            </person-group>
            <article-title>[Etiopathogenesis of ocular ischemic syndrome].</article-title>
            <source>Vestn Oftalmol</source>
            <year>2017</year>
            <volume>133</volume>
            <issue>2</issue>
            <fpage>120</fpage>
            <page-range>120-124</page-range>
            <pub-id pub-id-type="pmid">28524151</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17427.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCullough</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Reinert</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Hynan</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Albiston</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Inman</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Boyd</surname>
                <given-names>PI</given-names>
              </name>
              <name>
                <surname>Welborn</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Clagett</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Modrall</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Ocular findings as predictors of carotid artery occlusive disease: is carotid imaging justified?</article-title>
            <source>J Vasc Surg</source>
            <year>2004</year>
            <month>Aug</month>
            <volume>40</volume>
            <issue>2</issue>
            <fpage>279</fpage>
            <page-range>279-86</page-range>
            <pub-id pub-id-type="pmid">15297821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17427.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kvickstr&#x000f6;m</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lindblom</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bergstr&#x000f6;m</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zetterberg</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Amaurosis fugax: risk factors and prevalence of significant carotid stenosis.</article-title>
            <source>Clin Ophthalmol</source>
            <year>2016</year>
            <volume>10</volume>
            <fpage>2165</fpage>
            <page-range>2165-2170</page-range>
            <pub-id pub-id-type="pmid">27826182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17427.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hagiwara</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shimizu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hasegawa</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Contrast-enhanced transoral carotid ultrasonography for the diagnosis and follow-up of extracranial internal carotid artery dissection: A case report.</article-title>
            <source>J Clin Ultrasound</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>46</volume>
            <issue>5</issue>
            <fpage>368</fpage>
            <page-range>368-371</page-range>
            <pub-id pub-id-type="pmid">28990690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17427.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pula</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kwan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yuen</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Kattah</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Update on the evaluation of transient vision loss.</article-title>
            <source>Clin Ophthalmol</source>
            <year>2016</year>
            <volume>10</volume>
            <fpage>297</fpage>
            <page-range>297-303</page-range>
            <pub-id pub-id-type="pmid">26929593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17427.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayreh</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>OCULAR ARTERIAL OCCLUSIVE DISORDERS AND CAROTID ARTERY DISEASE.</article-title>
            <source>Ophthalmol Retina</source>
            <year>2017</year>
            <season>Jan-Feb</season>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>12</fpage>
            <page-range>12-18</page-range>
            <pub-id pub-id-type="pmid">28547004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17427.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McBride</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Porter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Al-Khaffaf</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>The modified operative technique of partial eversion carotid endarterectomy.</article-title>
            <source>J Vasc Surg</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>65</volume>
            <issue>1</issue>
            <fpage>263</fpage>
            <page-range>263-266</page-range>
            <pub-id pub-id-type="pmid">28010865</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17427.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prib&#x000e1;n</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Fiedler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chlouba</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>[Ocular symptoms as an indication for carotid endarterectomy].</article-title>
            <source>Cesk Slov Oftalmol</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>62</volume>
            <issue>5</issue>
            <fpage>354</fpage>
            <page-range>354-9</page-range>
            <pub-id pub-id-type="pmid">17039923</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17427.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reid</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Finney</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Hedges</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>The National Stroke Strategy - is it achievable?</article-title>
            <source>Ann R Coll Surg Engl</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>91</volume>
            <issue>8</issue>
            <fpage>641</fpage>
            <page-range>641-4</page-range>
            <pub-id pub-id-type="pmid">19686616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17427.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meyer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Karreman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kopriva</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Factors associated with delay in carotid endarterectomy for patients with symptomatic severe internal carotid artery stenosis: a case-control study.</article-title>
            <source>CMAJ Open</source>
            <year>2018</year>
            <month>May</month>
            <day>15</day>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>E211</fpage>
            <page-range>E211-E217</page-range>
            <pub-id pub-id-type="pmid">29769180</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17427.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pothof</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Zwanenburg</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Deery</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>O'Donnell</surname>
                <given-names>TFX</given-names>
              </name>
              <name>
                <surname>de Borst</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Schermerhorn</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>An update on the incidence of perioperative outcomes after carotid endarterectomy, stratified by type of preprocedural neurologic symptom.</article-title>
            <source>J Vasc Surg</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>67</volume>
            <issue>3</issue>
            <fpage>785</fpage>
            <page-range>785-792</page-range>
            <pub-id pub-id-type="pmid">29074118</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17427.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheng</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Vyas</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Velaga</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Davenport</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Saha</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>Outcomes of Carotid Endarterectomy with Primary Closure.</article-title>
            <source>Int J Angiol</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>83</fpage>
            <page-range>83-88</page-range>
            <pub-id pub-id-type="pmid">28566933</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
